Shiv Shan, Director, Red Nucleus

Shiv is an experienced consultant focused on solving challenges related to commercial strategy within the life science industry. Across his time at Red Nucleus (previously Jupiter Life Science Consulting) and Windrose Consulting Group, Shiv has worked on a wide variety of engagements including, asset valuation, value story development, pricing and market access strategy, payer and provider contracting strategy, and launch strategy.

He has deep experience in the rare diseases, inflammation and immunology, among other therapeutic areas (i.e., oncology, T2D, hematology). He is passionate about developing strategies to effectively communicate the value of therapies launching across global markets (i.e., US, EU, Asia-Pacific).